TAG:
integrated informatics
GE Pulls Plug on Its LIS, No Support after July 2013
By Robert Michel | From the Volume XVII No. 16 – November 15, 2010 Issue
CEO SUMMARY: Not in recent memory has a laboratory information system (LIS) product been pulled from the market. That is why the announcement by GE Healthcare that it would no longer service or support its Centricity Ultra Laboratory product after July 23, 2013, has caused a stir…
Systems Approach For Pre-Authorization Of Genetic Tests
By Robert Michel | From the Volume XVII No. 14 – October 4, 2010 Issue
CEO Summary: Pre-authorization of expensive genetic and molecular tests is a threat to local clinical laboratories and pathology groups if payers exclude them from provider networks in favor of labs which bid the lowest prices. But one major healthcare corporation believes there …
Payers Move to Pre-Authorize Expensive Genetic Tests
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO Summary: Pre-authorization of expensive genetic and molecular tests is fast-becoming a priority for most of the nationās health insurers. For clinical labs and pathology groups that donāt respond, this trend is a threat. On the other hand, because payers need all the skil…
Two New Pathology Models Will Soon Be Tried in Dallas
By Robert Michel | From the Volume XVII No. 4 – March 8, 2010 Issue
CEO SUMMARY: There are notable aspects to how and why four unlikely partners are banding together to invest $40 million and create the nationās newest reference and esoteric testing laboratory. It was the pathologists at Baylor University Hospital in Dallas, Texas, who originated the vi…
E-Prescribing Functions that Labs Can Offer Office-Based Physicians
By Robert Michel | From the Volume XVI No. 13 – September 21, 2009 Issue
IN RESPONSE TO MEDICARE AND PRIVATE PAYER efforts to increase physiciansā use of e-prescribing, 4Medica, Inc., of Culver City, California, was one of the first laboratory informatics vendors to add an effective e-prescribing capability to its lab test order and results reporting sy…
Multi-Modality Diagnosis Heading for Lab Medicine
By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue
CEO Summary: At the upcoming Molecular Summit in Philadelphia on February 10-11, 2009, pathologists, molecular imaging experts, and informaticians will share the latest developments on the integration of in vivo (imaging) and in vitro (pathology) diagnost…
War College 2008 Theme: Get Close to Customers!
By Robert Michel | From the Volume XV No. 7 – May 27, 2008 Issue
CEO SUMMARY: Over the course of two days, pathologists, lab directors, and other laboratory professionals repeatedly heard speakers urge them to work hard to ensure that customers are the top priority for their laboratory organization. Another theme is the need for labs to organize their …
Integrated In Vivo-In Vitro: Is It Pathologyās Future?
By Robert Michel | From the Volume XIV No. 17 – December 10, 2007 Issue
CEO SUMMARY: Across the globe, forward-thinking pathologists and radiologists are taking steps to use molecular technologies in ways that combine in vivo and in vitro testing. As this happens, traditional roles for pathology and radiology are likely to evolve toward a more integrated diag…
Emerging Global Trends in How Labs Are Using āDistributed Computingā
By Robert Michel | From the Volume XIV No. 7 – May 14, 2007 Issue
āIn several different countries, laboratories already use ādistributed computingā, in the form of a single LIS data center that provides informatics services to as many as 25 laboratories in a region. The trend is to increase interoperability and portability of the i…
Geisingerās Coag Clinics Located in Docsā Offices
By Robert Michel | From the Volume XIII No. 4 – March 20, 2006 Issue
CEO SUMMARY: It was six years ago when Geisinger Health System pushed laboratory testing and pharmacy services closer to the patients and referring physicians. By establishing coagulation clinics in six multi-specialty clinic sites, GeisingerĀ ha…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized